60 Degrees Pharmaceuticals, Inc. Share Price
NASDAQ: SXTP60 Degrees Pharmaceuticals, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
60 Degrees Pharmaceuticals, Inc. Share Price Chart
60 Degrees Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-18.55 | Revenue (TTM) $73771.00 | Return On Equity (TTM) -229.72% |
Profit Margin -10784.27% | Debt to Equity 0.53 | Quarterly Earnings Growth YoY -7.25% |
60 Degrees Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
60 Degrees Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
60 Degrees Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
SXTP Share Price FAQs
What is 60 Degrees Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of 60 Degrees Pharmaceuticals, Inc. stock?
What is SXTP's net income for the last quarter?
Can I buy SXTP shares in India?